CN1285225A - Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof - Google Patents
Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof Download PDFInfo
- Publication number
- CN1285225A CN1285225A CN 00109693 CN00109693A CN1285225A CN 1285225 A CN1285225 A CN 1285225A CN 00109693 CN00109693 CN 00109693 CN 00109693 A CN00109693 A CN 00109693A CN 1285225 A CN1285225 A CN 1285225A
- Authority
- CN
- China
- Prior art keywords
- gram
- stomach
- gastric
- developer
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to a formulation of two-dimensional ultrasonic stomach scanning developer and its preparation method. Said developer is a powder mixture made of pure Chinese medicinal materials including cuttlefish bone, tangerine peel, cinnamon bark and amonum fruit, etc, which possess auxiliary therapeutic action for curing gastropathy, and then the powder mixture can be capsulized so as to obtain the invented product. Said invented developer can be taken in one hour before test, in can effectively remove mucous in areae gastricae and interference of bubble, reduce the acoustic resistance, and eliminate acoustic reflex area opaca so as to make image clear, so that it is favourable for raising accuracy of clinical diagnosis.
Description
The invention belongs to clinical medicine and detect auxiliary synergist and preparation method thereof.When detecting, specifically a kind of gastric B ultrasonic examination strengthens special agent and its technology of image effect.
Ultrasonic examination is the basic means that present clinical medicine detects, and range of application is very extensive.B ultrasonic special construction and intracavity because of the gastric wall when doing stomachoscopy has mucus and the remaining acoustic resistance that causes of gas to strengthen more, even the generation dark space causes the inwall radiography smudgy, the quality that directly causes developed image, this is an obstacle during present gastric B ultrasonic examination is checked.Adopt the B ultrasonic synergist reduction acoustic resistance that removes obstacles for this reason at present, obtained effect preferably.Yet the B ultrasonic synergist is a chemical products, though not have body harmless with human body in principle, is not green product after all, and it is all worried and uneasy that the patient is produced, and on the high side be not ideal articles for use.
The purpose of this invention is to provide a kind of gastric B ultrasonic examination synergist and technology thereof that is mixed with natural animal-plant, make its feature that possesses green product, the characteristics of cheapness, produce effects are arranged again.
Key of the present invention is to select suitable pharmaceutical compositions according to the basic pharmacology that the traditional Chinese medical science helps digestion, regulates the flow of vital energy, and makes mixture, makes every effort to reach short time internal energy elimination gastric mucosa and residual gas, reaches the effect that reduces acoustic resistance and eliminate the acoustic reflection dark space.For this reason on the basis of traditional prescription through screening many times, selected recently be mixed with Chinese medicine gastric B ultrasonic examination synergist by following component weight.
Os sepiae 250-350 gram Pericarpium Citri Reticulatae 200-300 gram
Fructus Amomi 5-15 gram Cortex Cinnamomi 15-35 gram
Wheat tooth 18-22 gram Radix Et Rhizoma Rhei 4-6 gram
Radix Paeoniae Alba (parched) 8-12 gram Semen Coicis 15-25 gram
Radix Glycyrrhizae Preparata 9-11 gram
Above component is prepared raw material by weight, the Chinese herbal medicine method for processing is pulverized it and milling becomes powder routinely then, crosses 120 mesh sieves, again with powder in above-described ratio (by weight) proportioning mix homogeneously, the powder of mix homogeneously is incapsulated, and each capsule is 0.4～0.6 gram mixture.Promptly make finished product.
Person under inspection's fasting is 8-12 hour during application, and according to patient's stature body weight 1～3 of oral capsule before inspection, drinking-water 3OO～5O0 milliliter can be done inspection after 1-2 minute.Through clinical observation, take this agent and can obviously reduce gastric mucus and bubble, make echoless dark space in the gastral cavity.The image definition that reflection causes, each layer tissue structure of coat of the stomach is clear, and focus shows clearly outstanding, has reached its intended purposes of the present invention.
Above effect conclusion comes from following clinical observation contrast.
Observed content
1, cardia is to the pyloric cap form, gastric mucosa and coat of the stomach level, peristalsis;
2, tumor form, echo type and surrounding organ situation.
The composite authentication method:
Recombination rate with the sticking mutually difficult video picture judgement of gastroscope, operation or stomach.
The imaging results standard:
Good: the clear judgement cardia angular incisure of energy, size is curved at the bottom of the stomach, stomach cardia duodenum.Stomach interface and opaque dark area of fluid are clear, and the coat of the stomach level can be debated, and no steam bubble or mucus are disturbed.
Generally: body of stomach and gastric antrum all can show that the coat of the stomach level is not obvious, have mucus and bubble to disturb in the gastral cavity, but do not influence basic detection.
Bad: only can show gastric antrum and body of stomach profile, the coat of the stomach level is unable to recognize, and has a large amount of mucus and steam bubble to disturb normal the observation in the gastral cavity.
According to the standard of above formulation, take drug effect observation and matched group experiment being reported as follows after 254 hospitals of the Chinese People's Liberation Army carry out:
(1) drug effect observation report
Observe normal person 228, superficial gastritis patient 5380 people, patients with gastric cancer 180 people (contrast gastroscope, pathological section result diagnosis)
The efficacy of medicine observing report, acceptance rate has statistical significance more than 90%.
| Group | The example number | Good routine number (%) | Generally (%) | Bad (%) |
| The normal person | 228 | 214(93.9) | 12(5.2) | 2(0.9) |
| Superficial gastritis | 5380 | 5004(93) | 319(5.9) | 55(1) |
| Gastric cancer | 180 | 162(90) | 16(8.8) | 2(1.2) |
(2) matched group experiment contrast group respectively selects 100 people to do object, and wherein 100 people take drinking water before adopting detection, and 100 people obey into the developing agent capsule by concrete amount agent of the present invention in addition, judge developing result according to the image acquisition result then, add up as follows:
| Group | The example number | Good example (%) | General example (%) | Bad (%) |
| Drinking-water | 100 | 2(2) | 52(52) | 46(46) |
| Take medicine | 100 | 95(95) | 4(4) | 1(1) |
After taking medicine, more than report proof tangible effect is arranged to strengthening the gastric B ultrasonic examination image definition, it is the favourable guarantee that improves diagnostic accuracy, and selected medical material is tcm clinical practice medicine commonly used, do not have any poison and pay effect, and most pharmaceutical compositions all have corresponding curative effect to duodenal ulcer, hyperchlorhydria, gastrorrhagia etc., and play soothing liver-QI stomach function regulating activating qi for lowering adverse qi, antiinflammatory, analgesic assosting effect, none evil to doing patient's hundred benefits that stomach checks.And cost is low, application is convenient, effect is obvious, is the important improvement invention that gastric B ultrasonic examination is checked.
Provide below that embodiments of the invention the objective of the invention is how to realize furtherly:
Get any embodiment prescription, provide weight ratio, earlier its raw material is processed into medicated powder and crosses the capsule for medicine of packing into behind the mix homogeneously behind 120 mesh sieves, each 0.4-0.6 gram of packing into, can obtain comparatively ideal image when checking last hour and taking and show, and help clinical diagnosis, the raising greatly of accuracy rate.
Claims (2)
1, gastric B ultrasonic examination toner is characterized in that constituting (weight ratio) by following component:
Os sepiae 250-350 gram Pericarpium Citri Reticulatae 200-300 gram
Fructus Amomi 5-15 gram Cortex Cinnamomi 15-35 gram
Wheat tooth 18-22 gram Radix Et Rhizoma Rhei 4-6 gram
Radix Paeoniae Alba (parched) 8-12 gram Semen Coicis 15-25 gram
Radix Glycyrrhizae Preparata 9-11 gram.
2, a kind of processing technique of gastric B ultrasonic examination toner is characterized in that this technology takes following operation to finish:
A, by the prescription each component is assorted raw material by required weight,
B, classification are milled into powder, and cross 120 mesh sieves,
C, with all kinds of powders again by the described weight proportion of claim 1 with the medicated powder mix homogeneously,
D, the powder of mix homogeneously is divided in the capsule, contains 0.4-0.6 gram mixture in each capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00109693 CN1285225A (en) | 2000-06-22 | 2000-06-22 | Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00109693 CN1285225A (en) | 2000-06-22 | 2000-06-22 | Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1285225A true CN1285225A (en) | 2001-02-28 |
Family
ID=4579797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00109693 Pending CN1285225A (en) | 2000-06-22 | 2000-06-22 | Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1285225A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441180A (en) * | 2012-01-05 | 2012-05-09 | 王惠 | Gastrointestinal B-ultrasonic developer |
| CN104667305A (en) * | 2015-02-12 | 2015-06-03 | 郝爱华 | Gastrointestinal B-ultrasonography imaging agent |
-
2000
- 2000-06-22 CN CN 00109693 patent/CN1285225A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441180A (en) * | 2012-01-05 | 2012-05-09 | 王惠 | Gastrointestinal B-ultrasonic developer |
| CN102441180B (en) * | 2012-01-05 | 2013-01-23 | 王惠 | Gastrointestinal B-ultrasonic developer |
| CN104667305A (en) * | 2015-02-12 | 2015-06-03 | 郝爱华 | Gastrointestinal B-ultrasonography imaging agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1290568C (en) | Medicine for treating gastritis and gastrelcoma and its preparation method | |
| CN101804173B (en) | Traditional Chinese medicine composition for treating dyspepsia and preparation method thereof | |
| CN101869686B (en) | Chinese medicinal composition for treating cirrhosis | |
| CN101773633A (en) | Chinese medicine composition for treating gastric ulcer and preparation method thereof | |
| CN1785359A (en) | Chinese medicinal preparation for treating gastroenteric disease | |
| CN101780247A (en) | Traditional Chinese medicine composition for treating acute enteritis and preparation method thereof | |
| CN101780254B (en) | Traditional Chinese medicine compound for treating intestinal tumor | |
| CN103751739B (en) | The Chinese medicine composition for the treatment of chronic gastritis, its application in the medicine of preparation treatment chronic gastritis and preparation method thereof | |
| CN103272162A (en) | Traditional Chinese medicine composition for treating infertility and preparation method thereof | |
| CN102988656A (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN101780252B (en) | Traditional Chinese medicine compound for treating intestinal obstruction and preparation method thereof | |
| CN100548354C (en) | A kind of oral liquid for the treatment of nephropathy | |
| CN102552851B (en) | Traditional Chinese medicine for treating chronic gastrointestinal diseases | |
| CN104491884A (en) | Gastrointestinal contrast agent containing traditional Chinese medicine ingredients | |
| CN1285225A (en) | Stomach two-dimensinal ultrasonic ultrasonographic contrast powder and making technology thereof | |
| CN112022993A (en) | Traditional Chinese medicine composition for treating chronic gastritis and preparation process thereof | |
| CN101342360B (en) | Chinese medicinal composition for treating esophagus cancer | |
| CN101224293B (en) | Medicine for treating cholecystitis and superficial gastritis | |
| CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN103599367B (en) | Capsule for gastrointestinal ulcer and preparation technology thereof | |
| CN104436247A (en) | Contrast agent for detecting gastrointestinal diseases by ultrasonic wave and preparation method thereof | |
| CN101433649A (en) | Composition for treating gall stone symptom | |
| CN1381265A (en) | Medicine for treating cholecystitis and its preparing process | |
| CN101757601B (en) | Traditional Chinese medicine composite for treating esophageal rheumatism and preparation method thereof | |
| CN108578473A (en) | A kind of drug and preparation method thereof for treating stomachache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |